Partington-Anderson syndrome

Partington-Anderson syndrome, also known as Partington syndrome (PRTS), is a rare X-linked intellectual disability syndrome caused by mutations in the ARX (Aristaless-Related Homeobox) gene located on chromosome Xp21.3. The condition primarily affects males and is characterized by mild to moderate intellectual disability combined with dystonic movements of the hands, which is one of its most distinctive clinical features. Affected individuals typically display focal dystonia, particularly involving the hands and fingers, which can interfere with fine motor tasks. Speech and language development are often significantly delayed or impaired. The neurological system is the primary body system affected. Additional features may include ataxia (uncoordinated movements), seizures in some cases, and behavioral difficulties. The severity of symptoms can vary considerably even within the same family. Female carriers may occasionally show mild symptoms, such as subtle learning difficulties, but are generally much less severely affected than males. There is currently no cure for Partington syndrome. Management is supportive and symptomatic, focusing on speech therapy, occupational therapy to address fine motor difficulties related to dystonia, physical therapy, and special educational support. Medications may be used to manage dystonia or seizures when present. Genetic counseling is recommended for affected families to discuss recurrence risks and carrier testing for at-risk female relatives.

Common questions about Partington-Anderson syndrome